It's been about two weeks since they requested a meeting and that's about the timeline for the FDA to get one scheduled. The positive part of the PR is "conditional EUA", CD12 certainly has enough positive data to support an EUA while they conduct CD16. My guess is they filed for the conditional EUA with the protocol for CD16.